OXIS International, Inc. (OXIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile by GlobalData

VIEWS: 0 PAGES: 21

More Info
									          OXIS International, Inc. (OXIS) - Pharmaceuticals & Healthcare - Deals and
                                        Alliances Profile
       Reference Code: GDPH2235D                                                                                                              Publication Date: MAR 2013

      Company Overview                                                                                        Key Facts
      Oxis International, Inc. (Oxis) carries out research, development and marketing of
                                                                                                              OXIS International, Inc., Pharmaceuticals &
      products which prevents the harmful effects of oxidative stress and inflammation.
                                                                                                              Healthcare, Key Facts, 2011
      The company's finished products and finished product candidates include
      cosmeceutical products, therapeutic nutraceutical products, functional foods and                         Web Address                        www.oxis.com
      functional beverages. Primarily, the company concentrates on L-Ergothioneine
                                                                                                               Revenue (US$ million)                                     0.03
      (ERGO), a product which provides unique amino acid naturally occurring compound
      as a key component. Oxis owns a patented process to synthesize commercial                                Number of Employees                                         1
      quantities of ERGO. The company operates in North America; Europe, Middle East                           GlobalData
      and Africa; Latin America; Asia Pacific and various other countries.

      Financial Deals Landscape
        OXIS International, Inc., Pharmaceuticals & Healthcare, Deals by                  OXIS International, Inc., Pharmaceuticals & Healthcare,
        Type, 2007 to YTD 2013                                                            Deals By Year, 2007 to YTD 2013


                                                                                                                 2                                2
                                                                                                          2

                                                                                           No. of Deals
                                                                                                                          1         1     1                1
                                                                                                          1


                                                                                                                                                                     0
                                                                                                          0
                                                                                                               2007      2008   2009     2010    2011     2012   YTD
                                                                                                                                                                 2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         OXIS International, Inc., Pharmaceuticals & Healthcare,                          OXIS International, Inc., Pharmaceuticals & Healthcare,
         Deals By Region, 2007 to YTD 2013                                                Deals By Therapy Area, 2007 to YTD 2013

                         10     8                                                                         6          5          5
          No. of Deals




                                                                                           No. of Deals




                         8                                                                                5                               4           4
                         6                                                                                4                                                      3
                         4                                                                                3
                         2               1         1        1        1                                    2

                         0                                                                                1
                              North     Asia-    Europe   Middle   South                                  0
                              Americ   Pacific             East     and                                         Cardiov Central         Immun    Metabol Gastroi
                                a                          and     Central                                      ascular Nervou           ology      ic   ntestin
                                                          Africa   Americ                                                 s                      Disorde    al
                                                                     a                                                  System                      rs



         Note: Deals include all announced pharmaceuticals & healthcare deals             Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    from 2006 onwards, GlobalData




OXIS International, Inc. - Pharmaceuticals & Healthcare - Deals                                                                                   Reference Code: GDPH2235D
and Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                      Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       OXIS International, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ............................................................ 4
       OXIS International, Inc., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ............................................................. 5
       OXIS International, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ......................................................... 6
       OXIS International, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 .............................................. 7
       OXIS International, Inc., Medical Devices Deals, 2007 to YTD 2013 ................................................................................................. 8
       OXIS International, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 .......................................................... 9
       OXIS International, Inc., Pharmaceuticals & Healthcare, Deal Details ............................................................................................. 10
          Partnerships.................................................................................................................................................................................. 10
             OXIS International Forms Joint Venture With University Of Colorado ....................................................................................... 10
             OXIS International Enters Into Joint Venture Agreement With engage:BDR............................................................................. 11
          Licensing Agreements .................................................................................................................................................................. 12
             OXIS International Amends Licensing Agreement With Alteon ................................................................................................. 12
          Equity Offering .............................................................................................................................................................................. 13
             OXIS International Announces Private Placement Of Convertible Preferred Shares For $0.25 Million..................................... 13
             OXIS International Completes Private Placement Of $0.5 Million ............................................................................................. 14
          Debt Offering ................................................................................................................................................................................ 15
             Oxis International Completes Private Placement Of 12% Convertible Debentures For $1 Million ............................................ 15
             OXIS International Completes Private Placement Of Convertible Debentures For $2 Million ................................................... 16
          Asset Transactions ....................................................................................................................................................................... 17
             OXIS International Sells Its Assay Business Assets To Percipio .............................................................................................. 17
       OXIS International, Inc. - Key Competitors ....................................................................................................................................... 18
       Key Employees ................................................................................................................................................................................ 19
       Locations And Subsidiaries .............................................................................................................................................................. 20
          Head Office ................................................................................................................................................................................... 20
          Other Locations & Subsidiaries ..................................................................................................................................................... 20
       Appendix .........................................................................................................................
								
To top